Regulatory Insights
-
Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO
9/2/2025
In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional—it is essential to survival and success.
-
Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows
9/2/2025
Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.
-
The Resurgence Of Antibody-Drug Conjugates
9/1/2025
As advancements in ADC technology and clinical trial methodologies progress, Antibody-Drug Conjugates (ADCs) are poised to become pivotal in precision oncology.
-
Writing An IND Module 3 For Cell And Gene Therapy Products
9/1/2025
This whitepaper outlines the critical considerations for CGT Investigational New Drug (IND) Module 3, as well as how to avoid clinical holds and ensure regulatory readiness.
-
Navigating Project Optimus And The Rapidly Changing Oncology Development Landscape
9/1/2025
Project Optimus and adaptive trial designs are reshaping oncology development, improving patient outcomes, and streamlining approval pathways.
-
Accelerating Approval Pathway For Phase III Ovarian Cancer Trial
8/29/2025
A late-stage biotech developing a first-in-class therapy for a rare, chemo-resistant form of ovarian cancer sought help for accelerated FDA approval.
-
Prioritizing Safety In Clinical Trials
8/27/2025
This presentation explores organizational culture and the values that are essential to delivering high-quality safety oversight.
-
Why New Zealand Is Emerging As A Clinical Trial Hub
8/27/2025
New Zealand is rapidly emerging as a premier destination for clinical research, offering a unique combination of regulatory agility, scientific expertise, and cost efficiency.
-
Navigating The Regulatory Complexities Of Targeted Medicines In Oncology
8/22/2025
Explore the strategic considerations for successfully navigating the regulatory complexities of targeted medicines. Learn about the challenges in translational medicine and key clinical development considerations.
-
Project Orbis Drug Registration 2025
8/22/2025
Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.